IQVIA Holdings Inc. (IQV) Tax Rate: 15.62%
Is IQVIA Holdings Inc.’s tax rate high or low?
IQVIA Holdings Inc.'s tax rate of 15.62% is in line with its 5-year average of 15.48%, near the high end of its 5-year range (6.92%–19.25%).
The tax rate for IQVIA Holdings Inc. (IQV) is 15.62%. It is below its 12-month average by 6.35% (16.68%).
IQV Tax Rate Chart
IQV Average Tax Rate Chart
IQV Current vs Average Tax Rate Chart
IQV Tax Rate Metrics
TAX RATE
15.62%
TAX RATE AVG TTM
16.68%
TAX RATE AVG 3Y
14.88%
TAX RATE AVG 5Y
15.48%
TAX RATE AVG 10Y
-6.18%
TAX RATE AVG 15Y
4.00%
TAX RATE AVG 20Y
4.00%
CURRENT VS TTM AVG
-6.35%
CURRENT VS 3Y AVG
+4.96%
CURRENT VS 5Y AVG
+0.94%
CURRENT VS 10Y AVG
+352.71%
CURRENT VS 15Y AVG
+290.81%
CURRENT VS 20Y AVG
+290.81%
IQVIA Holdings Inc. Tax Rate Formula & Definition
Tax rate measures income tax expense as a percentage of income before tax. It helps compare tax efficiency and identify unusual tax effects.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
IQVIA Holdings Inc. Tax Rate FAQ
- What is the tax rate for IQVIA Holdings Inc. (IQV)?
- The tax rate for IQV stock is 15.62%.
- Is IQVIA Holdings Inc.'s tax rate high or low?
- IQVIA Holdings Inc.'s tax rate of 15.62% is in line with its 5-year average of 15.48%, near the high end of its 5-year range (6.92%–19.25%).
- What is the TTM average tax rate for IQVIA Holdings Inc. (IQV)?
- The TTM average tax rate for IQV stock is 16.68%.
- What is the 3Y average tax rate for IQVIA Holdings Inc. (IQV)?
- The 3Y average tax rate for IQV stock is 14.88%.
- What is the 5Y average tax rate for IQVIA Holdings Inc. (IQV)?
- The 5Y average tax rate for IQV stock is 15.48%.
- What is the 10Y average tax rate for IQVIA Holdings Inc. (IQV)?
- The 10Y average tax rate for IQV stock is -6.18%.
- What is the 15Y average tax rate for IQVIA Holdings Inc. (IQV)?
- The 15Y average tax rate for IQV stock is 4.00%.
- What is the 20Y average tax rate for IQVIA Holdings Inc. (IQV)?
- The 20Y average tax rate for IQV stock is 4.00%.
IQVIA Holdings Inc. Tax Rate History
| DATE | TAX RATE |
|---|---|
| 2025-12-31 | 15.62% |
| 2024-12-31 | 17.74% |
| 2023-12-31 | 6.92% |
| 2022-12-31 | 19.25% |
| 2021-12-31 | 14.37% |
| 2020-12-31 | 18.95% |
| 2019-12-31 | 33.82% |
| 2018-12-31 | 17.20% |
| 2017-12-31 | -324.67% |
| 2016-12-31 | 83.74% |
| 2015-12-31 | 29.07% |
| 2014-12-31 | 29.66% |
| 2013-12-31 | 29.70% |
| 2012-12-31 | 34.58% |
| 2011-12-31 | 5.91% |
| 2010-12-31 | 32.09% |
Related Metrics
About IQVIA Holdings Inc.
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Ari Bousbib